Dr. Ankur Bahl

About Doctor

Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 14 years of experience in the field. He is an alumnus of Maulana Azad Medical College, Delhi, and did his MBBS followed by MD in Medicine.

He has done his DM in Medical Oncology from the prestigious All India Institute of Medical Sciences, New Delhi. He also holds a course on Adverse Drug Reactions, Drug Interactions, and pharmaco vigilance at the University of Oxford UK.

Dr. Bahl's clinical expertise is in Immunotherapy, targeted therapies in combination with chemotherapy and hormonal therapy along with supportive and palliative care.

He is the lead author of the largest real-world Indian data on targeted therapy (Cetuximab) in Head and neck cancer, Acute Myeloid leukemia treatment, Human Papillomavirus trends in the Indian Population, etc.

He also founded various innovative oncology educational platforms and networks that have been proven to be effective in educating medical professionals.

He joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and Hematology Oncology.

Previously he was associated with prestigious organizations like Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.

Medical Qualifications

• MBBS, From Maulana Azad Medical College, Delhi University, 2003
• MD, From Maulana Azad Medical College, Delhi University, 2007
• DM, From All India Institute of Medical Sciences (AIIMS), New Delhi, 2012

Clinical Expertise

Professional Work Experience

• He was the Director of Medical Oncology and  Hematology oncology at Max Healthcare Saket from June 2021 to September 2021.
• He was a Senior Consultant in Medical Oncology at  Max Healthcare SakeNew Delhi from January 2017 to May 2021.
• He was a Consultant in Medical Oncology at Max Healthcare Saket New Delhi from 2013 to 2016.
• From June 2007 to February 2009, he worked as a Senior Resident in the Department of Medicine at  Maulana Azad Medical College, New Delhi.
• From February 2009 to December 2009, he was a DNB Fellow in the Department of Medical Oncology, RGCI & RC, New Delhi.

Career Highlights

• Dr. Bahl is a member of ASCO (American Society of Clinical Oncology).
• He has a professional membership of AACR (American Association of Cancer Research).
• He also has a membership of the European Society of Medical Oncology
• Professional membership of India Society of Medical & Pediatric Oncology (ISMPO)
• Global EGFR Advisory Network member.
• Dr Bahl also has a professional membership of ICON (Indian Cooperative Oncology Network).
• He’s also a Core Committee member of the Immuno-oncology network in India.

Research and Fellowships

• Innumerable Publications in International and National Journal / Books of repute.
• He is a lead Author of largest real world Indian data on Targeted therapy (Cetuximab )in head and neck cancer, Acute Myeloid leukemia treatment, Human Papilloma Virus trends in Indian Population etc.
• He is also the lead founder of various innovative oncology educational platforms and networks (International and national) Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes and workshops in oncology.
• He is a professional guide for international and national medical oncology fellows and students.
• He serves as an advisor to various biopharmaceutical research and development companies.
• Dr Bahl has lead various NGOs for "No Tobacco" workshop for teens in Delhi Schools

Awards and Recoginition

• He was the recipient of Dr. Rehan Gold Medal for being the best Outgoing Post Graduate student of Internal Medicine in Delhi University.